Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab

Hagop M. Kantarjian, Aaron C. Logan, Faraz Zaman, Nicola Gökbuget, Ralf C. Bargou, Yi Zeng, Gerhard Zugmaier, Franco Locatelli

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab'. Together they form a unique fingerprint.

Medicine & Life Sciences